🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hanzhou
Clinical trial register · China

Clinical Trials in Hanzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine13 Sir Run Run Shaw Hospital6 The Affiliated Hospital of Hangzhou Normal University4 Wenzhou Medical University2 First Affiliated Hospital of Zhejiang University2
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Hanzhou

44 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Prospective Cohort Study of Aging in Patients With Acute Myocardial Infarction
NCT07705997Acute Myocardial Infarction (AMI)
The Affiliated Hospital of Hangzhou Normal University
Observational
600
Hanzhou
2026-08-01
Not yet open
Cardiovascular Risk in T2DM With MAFLD: A Cohort Study
NCT07706010Type 2 Diabetes (T2DM), Metabolic Dysfunction-Associated Steatotic Liver Disease
The Affiliated Hospital of Hangzhou Normal University
Observational
7,000
Hanzhou
2026-07-12
Recruiting
the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
NCT06527326Central Serous Chorioretinopathy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
400
Hanzhou
2026-05-27
Not yet open
Chinese Cardiologists' Knowledge/Practices on Flu Vaccine for Chronic Coronary Syndrome
NCT06991088Chinese Cardiologists
The Affiliated Hospital of Hangzhou Normal University
Observational
5,000
Hanzhou
2025-06
Not yet open
The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC
NCT06895369Squamous Cell Carcinoma of Head and Neck
Sir Run Run Shaw Hospital
Phase 2
30
Hanzhou
2025-05-01
Not yet open
Comparing Monofocal IOLs in Highly Myopic Cataract Patients
NCT06905938Cataract
Wenzhou Medical University
Observational
60
Hanzhou
2025-04-01
Active, closed
Visual Quality of Cataract Patients with High Myopia After Implantation of Different Intraocular Lenses
NCT06892470Cataract
Wenzhou Medical University
Observational
62
Hanzhou
2025-03-01
Not yet open
A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer
NCT06838546Advanced Colorectal Cancer
Tasly Biopharmaceuticals Co., Ltd.
Phase 2
80
Hanzhou
2025-02-24
Active, closed
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
NCT06619236Platinum-resistant Ovarian Cancer
Genmab
Phase 3
530
Guangzhou, Xi'an, Changchun, Hanzhou, Shanghai, Tianjin, Zhengzhou
2025-02-07
Recruiting
Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza
NCT06574503Influenza
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 3
748
Hanzhou
2024-12-01
Recruiting
Acute Effects of Meteorological Factors and Air Pollution on Cardiovascular Health
NCT06663267Cardiovascular System, Health
The Affiliated Hospital of Hangzhou Normal University
Observational
350,000
Hanzhou
2024-11
Recruiting
CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
NCT06633328Aplastic Anemia
Zhejiang University
Phase EARLY_PHASE1
30
Hanzhou
2024-10-20
Recruiting
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)
NCT06590246Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.
Phase 1/2
121
Shanghai, Hanzhou
2024-09-30
Not yet open
A Study of Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma
NCT06586294Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Akeso
Phase 1/2
294
Hanzhou
2024-09-10
Recruiting
A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma
NCT06554561PCNSL
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
43
Hanzhou
2024-08-31
Recruiting
A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT06554600Refractory or Relapsed Diffuse Large B Cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
36
Hanzhou
2024-08-31
Recruiting
A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma
NCT06556199Relapsed/Refractory Primary Central Nervous System Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
38
Hanzhou
2024-08-31
Active, closed
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer
NCT06507371Rectal Cancer
Sir Run Run Shaw Hospital
Phase 3
170
Hanzhou
2024-07-29
Recruiting
Application of an Early In-Hospital Temperature Management Protocol for Heat Stroke Patients
NCT06537557Heat Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
188
Guli, Dongyang, Hanzhou, Jinhua, Lanxi, Yiwu
2024-07-01
Recruiting
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
NCT05831085Coronary Artery Stenosis
Duk-Woo Park, MD
Not applicable
1,500
Beijing, Hanzhou
2024-06-14
Not yet open
Effectiveness of Robotic Surgery for Right Colon Cancer
NCT06421974Colon Cancer, Robotic Surgery
Sir Run Run Shaw Hospital
Not applicable
610
Hanzhou
2024-06-01
Recruiting
Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases
NCT06520774Aortic Arch Aneurysm, Penetrating Aortic Ulcer
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
103
Beijing, Changsha, Chengdu, Fuzhou, Hanzhou, Kunming, Nanjing, Shanghai
2024-05-30
Recruiting
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
NCT06375044Relapsed or Refractory Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
130
Beijing, Fuzhou, Guangzhou, Zhengzhou, Nanjing, Tianjin, Hanzhou
2024-05-24
Recruiting
Micro-movements in Patients With Prolonged Disorders of Consciousness
NCT06406413Consciousness Disorders
First Affiliated Hospital of Zhejiang University
Observational
179
Hanzhou
2024-05-01
Recruiting
the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave
NCT06543602Critically Ill Patients
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
580
Hangzhou, Hanzhou
2024-05-01
Recruiting
Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer
NCT06167967Colorectal Cancer
Sir Run Run Shaw Hospital
Not applicable
990
Hanzhou
2024-04-08
Recruiting
The Hi-tACS on Cognitive Function in Patients With Schizophrenia
NCT06470516Schizophrenia
Sir Run Run Shaw Hospital
Not applicable
100
Hanzhou, Quzhou
2024-04-01
Recruiting
A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I
NCT06162338Gaucher Disease Type I
He Huang
Not applicable
3
Hanzhou
2023-11-15
Recruiting
Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer
NCT05972655Low Rectal Cancer
Sir Run Run Shaw Hospital
Phase 2
32
Hanzhou
2023-08-02
Not yet open
Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer
NCT05841849Breast Cancer, Chemotherapy-induced Nausea and Vomiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
1,028
Hanzhou
2023-07
Recruiting
GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence
NCT05557578Intrahepatic Cholangiocarcinoma
Zhejiang Cancer Hospital
Phase 2
20
Hangzhou, Hanzhou
2023-05-05
Recruiting
Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
NCT05212454Breast Cancer, Chemotherapy Effect
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
400
Hanzhou
2023-03-15
Recruiting
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
NCT05586074Leukemia, Acute Myeloid (AML)
Sunshine Lake Pharma Co., Ltd.
Phase 3
324
Hanzhou
2023-03-03
Recruiting
Study of Comparing of With and Without Sequential Therapy of S-1
NCT05813015Locally Advanced Gastric Adenocarcinoma, Chemotherapy Effect
Zhejiang University
Phase 3
70
Hanzhou
2023-01-28
Recruiting
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
NCT05133882Acute Myeloid Leukemia, Adult
Sunshine Lake Pharma Co., Ltd.
Phase 1/2
133
Hanzhou
2022-10-31
Recruiting
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
NCT05507411Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital
Phase 2
100
Hanzhou, Ningbo
2022-08-03
Recruiting
Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma
NCT05600660Primary Central Nervous System Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
28
Hanzhou
2022-08-01
Recruiting
Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL
NCT05472558B-cell Non Hodgkin Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
48
Hanzhou
2022-07-26
Recruiting
A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors
NCT05217693Solid Tumor
Bliss Biopharmaceutical (Hangzhou) Co., Ltd
Phase 1
288
Beijing, Changsha, Ganzhou, Hangzhou, Hanzhou, Linyi, Nanjing
2022-06-01
Recruiting
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
NCT05147467Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Ascentage Pharma Group Inc.
Phase 2
75
Guangzhou, Haikou, Zhengzhou, Wuhan, Suzhou, Nanchang, Tianjin, Hanzhou
2021-12-28
Recruiting
Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
NCT04778839Advanced Solid Tumors
First Affiliated Hospital of Zhejiang University
Phase 1
98
Hanzhou
2021-03-04
Recruiting
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NCT04078230Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
168
Beijing, Guangzhou, Changsha, Hohhot, Shanghai, Xi’an, Chengdu, Hanzhou
2020-01-01
Recruiting
Application of Radiomics in Breast Cancer
NCT04483804Breast Cancer, Ultrasound, Elastography, Pathology
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
2,000
Hanzhou
2018-01-01
Recruiting
Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
NCT02803294Symptomatic Aortic Stenosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
2,000
Hanzhou
2016-06
Rows per page Showing 1–44 of 44
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/hanzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 44 of those studies with a site in Hanzhou.

How many clinical trials are recruiting in Hanzhou?

32 of the 44 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 9 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hanzhou), 44 studies
PhaseStudiesRecruitingShare
Not applicable9820.5%
Observational9420.5%
Phase 28618.2%
Phase 36413.6%
Phase 1/25411.4%
Phase 1449.1%
Phase 4214.5%
Phase EARLY_PHASE1112.3%

Most active sponsors

Lead sponsors with the most studies (Hanzhou)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine1312
Sir Run Run Shaw Hospital63
The Affiliated Hospital of Hangzhou Normal University41
First Affiliated Hospital of Zhejiang University22
Sunshine Lake Pharma Co., Ltd.22
Wenzhou Medical University20
Zhejiang Cancer Hospital22
Zhejiang University22
Akeso10
Ascentage Pharma Group Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.